Lumexa Imaging Holdings Inc

Lumexa Imaging Holdings Inc(LMRI)の株式分析

$11.510

-0.216 (-1.88%)終値時点

Loading chart…
High
12.105
Open
11.770
VWAP
11.67
Vol
342.62K
Mkt Cap
Low
11.410
Amount
4.00M
EV/EBITDA, TTM
21.86

Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.

AI analysis of Lumexa Imaging Holdings Inc (LMRI)

hold

Lumexa Imaging Holdings, Inc. is currently not a strong buy due to a recent RSI of 38.778 indicating oversold conditions, alongside a significant year-to-date change of -34.42%. However, the company has shown improvement in profitability with a net income of $2.7 million in Q2 2026, suggesting potential for recovery. The main risk is the high debt level, with a debt-to-equity ratio of 144.68%, which could impact financial stability.

バリュエーション指標

The current forward P/E ratio for Lumexa Imaging Holdings Inc (LMRI) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
割高
0.00
割安
0.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
38.47
Current EV/EBITDA
21.86
割高
64.23
割安
12.71

Forward P/S

Fair
5Y Average P/S
0.89
Current P/S
1.00
割高
1.22
割安
0.56

Whales holding LMRI

S

Seven Grand Managers LLC

+ HoldingLMRI

-6.64%

3M Return

イベントタイムライン

2026-08-12 (ET)

17:00:00

Lumexa Imaging Reports Q2 Revenue of $264.16M

17:00:00

Company Adjusts FY26 Revenue Outlook to $1.05B-$1.1B

2026-06-02 (ET)

07:30:00

Lumexa Imaging Forms Strategic Joint Venture with Hospital for Special Surgery

2026-04-20 (ET)

07:10:00

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

2026-03-26 (ET)

09:40:00

Lumexa Imaging Holdings Inc Trading Resumes

ニュース

LMRI FAQ — answered by Alphio AI

Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems. It operates in the Healthcare sector.

Lumexa Imaging Holdings, Inc. is currently not a strong buy due to a recent RSI of 38.778 indicating oversold conditions, alongside a significant year-to-date change of -34.42%. However, the company has shown improvement in profitability with a net income of $2.7 million in Q2 2026, suggesting potential for recovery. The main risk is the high debt level, with a debt-to-equity ratio of 144.68%, which could impact financial stability.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める